Nevertheless, follow-up studies are needed to fully clarify the role of bilirubin in CRC development; for example, by conducting a multivariable MR [59], where bilirubin is jointly instrumented with potential other phenotype(s) that could be associated with UGT1A1 variants. The gene discussed is UGT1A1; the disease is colorectal carcinoma.